Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1949) 1949
Book Chapter (40) 40
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1580) 1580
science & technology (1456) 1456
life sciences & biomedicine (1431) 1431
diabetes mellitus, type 2 - drug therapy (1115) 1115
hypoglycemic agents - therapeutic use (823) 823
type 2 diabetes (768) 768
endocrinology & metabolism (723) 723
incretins - therapeutic use (654) 654
diabetes (651) 651
male (538) 538
animals (525) 525
female (461) 461
dipeptidyl-peptidase iv inhibitors - therapeutic use (417) 417
glucose (391) 391
incretin (391) 391
insulin (361) 361
incretins (355) 355
middle aged (347) 347
diabetes mellitus, type 2 - blood (334) 334
treatment outcome (333) 333
glucagon (331) 331
hypoglycemic agents - adverse effects (325) 325
blood glucose - metabolism (311) 311
pharmacology & pharmacy (281) 281
glucagon-like peptide 1 - therapeutic use (276) 276
glp-1 (270) 270
diabetes mellitus (258) 258
diabetes mellitus, type 2 - metabolism (258) 258
blood glucose - drug effects (248) 248
liraglutide (248) 248
glucagon-like peptide 1 - analogs & derivatives (245) 245
peptides (245) 245
aged (244) 244
dextrose (236) 236
adult (228) 228
diabetes therapy (223) 223
biological and medical sciences (222) 222
hypoglycemic agents - pharmacology (222) 222
hypoglycemic agents - administration & dosage (218) 218
incretins - metabolism (216) 216
internal medicine (216) 216
hypoglycemic agents (215) 215
care and treatment (206) 206
medical sciences (205) 205
insulin - metabolism (203) 203
risk factors (201) 201
diabetes mellitus, type 2 - complications (196) 196
drug therapy (195) 195
insulin resistance (195) 195
obesity (195) 195
glucagon-like peptide-1 receptor (192) 192
exenatide (191) 191
general & internal medicine (188) 188
diabetes mellitus, type 2 - physiopathology (187) 187
glucagon-like peptide-1 (187) 187
peptides - therapeutic use (187) 187
analysis (182) 182
glucagon-like peptide 1 - metabolism (181) 181
incretins - adverse effects (181) 181
type 2 diabetes mellitus (177) 177
drug therapy, combination (176) 176
abridged index medicus (173) 173
glucagon-like peptide 1 (171) 171
medicine, general & internal (170) 170
insulin secretion (166) 166
venoms - therapeutic use (164) 164
medicine & public health (160) 160
endocrinopathies (157) 157
review (156) 156
incretins - pharmacology (153) 153
metformin - therapeutic use (153) 153
glucagon-like peptide-1 receptor - agonists (152) 152
health aspects (152) 152
diabetes. impaired glucose tolerance (151) 151
endocrine pancreas. apud cells (151) 151
etiopathogenesis. screening. investigations. target tissue resistance (143) 143
receptors, glucagon - agonists (143) 143
insulin - therapeutic use (142) 142
research (140) 140
clinical trials (138) 138
cardiovascular system & cardiology (137) 137
dipeptidyl-peptidase iv inhibitors - adverse effects (129) 129
endocrine system (129) 129
physiological aspects (127) 127
glycated hemoglobin a - metabolism (126) 126
hyperglycemia (126) 126
digestive, oral, and skin physiology (124) 124
insulin - blood (123) 123
incretins - administration & dosage (121) 121
dipeptidyl-peptidase iv inhibitors - pharmacology (119) 119
glucose metabolism (117) 117
mice (117) 117
insulin-secreting cells - drug effects (115) 115
sitagliptin phosphate (115) 115
adamantane - analogs & derivatives (113) 113
hormones, hormone substitutes, and hormone antagonists (112) 112
sitagliptin (112) 112
double-blind method (110) 110
cardiac & cardiovascular systems (108) 108
hypoglycemia (108) 108
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1909) 1909
Japanese (20) 20
Spanish (19) 19
German (17) 17
Czech (15) 15
French (13) 13
Hungarian (7) 7
Russian (6) 6
Italian (4) 4
Portuguese (4) 4
Danish (3) 3
Norwegian (3) 3
Polish (3) 3
Croatian (2) 2
Swedish (2) 2
Chinese (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Options for Combination Therapy in Type 2 Diabetes: Comparison of the ADA/EASD Position Statement and AACE/ACE Algorithm
by Bailey, Timothy, MD
The American journal of medicine, ISSN 0002-9343, 2013, Volume 126, Issue 9, pp. S10 - S20
Internal Medicine | Type 2 diabetes | Position statement | Treatment guidelines | Algorithm | Patient management | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Metformin - therapeutic use | Glucagon-Like Peptide 1 - analogs & derivatives | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Sulfonylurea Compounds - therapeutic use | Thiazolidinediones - therapeutic use | Algorithms | Glucagon-Like Peptide-1 Receptor | Piperidines - therapeutic use | Venoms - therapeutic use | Incretins - therapeutic use | Carbamates - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Insulin - therapeutic use | Liraglutide | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Practice Guidelines as Topic | Medical protocols | Care and treatment | Drug therapy, Combination | Analysis | Standards | Diabetes | Primary care | Medical treatment | Clinical outcomes | Endocrinology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text DPP-4 inhibitors: What may be the clinical differentiators?
by Gerich, John
Diabetes research and clinical practice, ISSN 0168-8227, 2010, Volume 90, Issue 2, pp. 131 - 140
Endocrinology & Metabolism | Type 2 diabetes | DPP-4 | GLP-1 | Gliptins | Dipeptidyl peptidase-4 | Life Sciences & Biomedicine | Science & Technology | Dipeptidyl Peptidase 4 - drug effects | Intestinal Mucosa - physiopathology | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Glycated Hemoglobin A - drug effects | Pyrazines - therapeutic use | Intestinal Mucosa - drug effects | Pyrrolidines - therapeutic use | Neurons - physiology | Adamantane - therapeutic use | Linagliptin | Purines - therapeutic use | Sitagliptin Phosphate | Neurons - drug effects | Incretins - physiology | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - classification | Hyperglycemia - prevention & control | Dipeptides - therapeutic use | Uracil - therapeutic use | Energy Intake | Blood Glucose - drug effects | Intestinal Mucosa - physiology | Gastric Emptying - drug effects | Piperidines - therapeutic use | Quinazolines - therapeutic use | Incretins - secretion | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide 1 - therapeutic use | Nitriles - therapeutic use | Uracil - analogs & derivatives | Hyperglycemia | Hypoglycemic agents | Peptides | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
by Rotman, Yaron and Sanyal, Arun J
Gut, ISSN 0017-5749, 01/2017, Volume 66, Issue 1, pp. 180 - 190
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Peroxisome Proliferator-Activated Receptors - agonists | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Receptors, Cytoplasmic and Nuclear - agonists | Drug Repositioning | Molecular Targeted Therapy | Drug Discovery | Anti-Obesity Agents - therapeutic use | Chenodeoxycholic Acid - analogs & derivatives | Non-alcoholic Fatty Liver Disease - drug therapy | Antioxidants - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipogenesis - drug effects | Chenodeoxycholic Acid - therapeutic use | Incretins - therapeutic use | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Immunologic Factors - therapeutic use | Drugs | Usage | Care and treatment | Liver diseases | Diagnosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Impact of Diabetes and Diabetes Medications on Bone Health
by Gilbert, Matthew P and Pratley, Richard E
Endocrine reviews, ISSN 0163-769X, 04/2015, Volume 36, Issue 2, pp. 194 - 213
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Hip Fractures - metabolism | Bone Density | Metformin - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Sulfonylurea Compounds - therapeutic use | Fractures, Bone - epidemiology | Diabetes Mellitus, Type 2 - metabolism | Hip Fractures - epidemiology | Fractures, Bone - metabolism | Diabetes Mellitus, Type 2 - epidemiology | Thiazolidinediones - therapeutic use | Bone and Bones - metabolism | Incretins - therapeutic use | Islet Amyloid Polypeptide - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Bone Remodeling | Insulin - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights